Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug treatment of laryngopharyngeal reflux
ISRCTN03482154Phase 3Terminated
- Sponsor
- University of Southampton
- Start
- Jan 2013
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
01
Overview
Phase 3, randomised, double-blind trial of omeprazole, gaviscon advance, Sodium alginate and potassium bicarbonate in laryngopharyngeal reflux (LPR) (4 arms), sponsored by University of Southampton. Started Jan 2013; status: terminated.
02
Drugs
omeprazolegaviscon advanceSodium alginatepotassium bicarbonate
03
Conditions
laryngopharyngeal reflux (LPR)
Beyond the preview
Go deeper on ISRCTN03482154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN03482154.